Recall events
/
Event 67881
Event summary
Timeline bucket January 31, 2014
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording American Health Packaging
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
HydrOXYzine HCl Tablets, USP 25 mg, 100 Tablet Blister, Rx only Mfd by: KVK-TECH, INC. Newtown, PA 18940, NDC 68084-254-01
D-1188-2014
Recall number D-1188-2014
Initiated January 31, 2014
Classification Class II
Status Terminated
Quantity 14,665 blister packs
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
Good Manufacturing Practices Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.
Code information Lot 120407, Exp 01/14; Lot 121337 Exp 03/14; Lot 122054, Exp 05/14; Lot 122598, Exp 06/14; Lot 130125, Exp 12/14
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4621]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
HydrOXYzine HCl Tablets, USP 50 mg, 100 Tablet Blister, Rx only Mfd by: KVK-TECH, INC. Newtown, PA 18940, NDC 68084-255-01
D-1189-2014
Recall number D-1189-2014
Initiated January 31, 2014
Classification Class II
Status Terminated
Quantity 8,570 blister packs
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
Good Manufacturing Practices Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.
Code information Lot 120757, Exp. 02/14; Lot 121104, Exp 03/14; Lot 122055, Exp 05/14; Lot 123038, Exp 07/14; Lot 125115, Exp 11/14
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4812]
FDA event record
· Exact recall-number query on openFDA